| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 08/12/2022 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 01/08/2025 |
James Henson
COO | Chief Operating Officer | 39 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Jörn Andreas
BRD | Director/Board Member | 45 | 01/01/2014 |
| Chairman | 62 | 01/04/2015 | |
| Director/Board Member | 64 | 04/05/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/2/25 | Buy | Company | 142,586 | 1.2514% | ||
| 21/1/25 | Buy | Company | 2,840,101 | 24.9260% | ||
| 28/11/24 | Buy | Company | 33,086 | 0.2904% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.29% | - | - | 33.68M | ||
| +0.69% | -5.54% | +58.51% | +109.17% | 1,031B | ||
| +1.04% | -1.61% | +50.94% | +67.47% | 641B | ||
| +0.90% | -2.59% | +22.17% | +74.70% | 453B | ||
| -1.50% | -7.04% | +33.55% | +33.94% | 349B | ||
| +6.25% | +2.04% | +28.97% | +46.57% | 290B | ||
| -0.07% | -4.12% | +0.95% | +11.79% | 252B | ||
| +0.35% | -2.34% | +50.52% | +68.23% | 232B | ||
| +0.51% | -4.52% | -19.50% | -54.83% | 201B | ||
| +1.33% | -0.26% | +31.66% | +93.59% | 181B | ||
| Average | +0.85% | -2.98% | +28.64% | +50.07% | 403.31B | |
| Weighted average by Cap. | +0.89% | -3.97% | +37.72% | +66.05% |
Employees
-
Sector
Pharmaceuticals
















